This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Nuralogix Corporation. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Yousef Yasin
Introduction
Yousef Yasin is a prominent inventor based in Toronto, Canada. He has made significant strides in the field of medical technology, particularly in the quantification of blood biomarkers. His work is characterized by the integration of machine learning and imaging techniques to enhance healthcare diagnostics.
Latest Patents
Yousef Yasin holds a patent for a groundbreaking invention titled "System and method for camera-based quantification of blood biomarkers." This patent describes systems and methods for determining the concentration of one or more blood biomarkers in a human subject. The method involves using a first machine learning model trained with a hemoglobin concentration changes training set. It analyzes bit values from a set of bitplanes in a captured image sequence that represent the hemoglobin concentration changes of the subject. The innovation aims to improve the accuracy and efficiency of blood biomarker analysis.
Career Highlights
Yousef Yasin is associated with Nuralogix Corporation, where he applies his expertise in developing advanced healthcare solutions. His work focuses on leveraging technology to provide better health insights and improve patient outcomes. With a patent portfolio that includes 1 patent, he continues to push the boundaries of innovation in medical diagnostics.
Collaborations
Yousef collaborates with talented professionals in his field, including Kang Lee and Andrew Barszczyk. Their combined efforts contribute to the advancement of technology in healthcare, fostering an environment of innovation and creativity.
Conclusion
Yousef Yasin's contributions to the field of medical technology exemplify the impact of innovation on healthcare. His patented methods for quantifying blood biomarkers represent a significant advancement in diagnostic capabilities. Through his work at Nuralogix Corporation, he continues to influence the future of medical diagnostics and improve patient care.